Hereditary xerocytosis (HX) is thought to be a rare genetic condition characterized by red blood cell (RBC) dehydration with mild hemolysis. Gain-of-function (GOF) mutations in mechanosensitive Piezo1 ion channels are identified in HX patients. RBC dehydration is linked to reduced Plasmodium infection rates in vitro. We engineered a Piezo1 mouse model of HX and show that Plasmodium infection fails to cause experimental cerebral malaria in these mice. Furthermore, we identified a novel GOF human Piezo1 variant, E756del, present in a third of African population. Remarkably, RBCs from individuals carrying this allele are dehydrated and protected against Plasmodium infection in vitro. The presence of an HX-causing Piezo1 mutation at such high frequencies in African population is surprising, and suggests an association with malaria resistance.
hypotonicity-dependent hemolysis challenge (Fig. 1C-D) . This suggested that RBCs from Piezo1 GOF knock-in mice are more resistant to lysis in response to hypotonic solutions compared to wild type, a defining feature for HX (13) . In addition, we assessed the hematological properties of whole blood from Piezo1 GOF mice (Table S1) . As in HX patients, both heterozygote and homozygote knock-in mice display mild anemia, indicated by a lower hemoglobin (HGB) level and increased reticulocyte number (RET). Shifts in Mean Corpuscular Volume (MCV) and Mean Corpuscular Hemoglobin (MCH) values are reminiscent of HX patients. In addition, scanning electron microscopy showed that some RBCs from piezo1cx/+; vav1-cre have deformed and dehydrated shapes, as is often observed in blood from HX patients (Fig. 1E) . Spleen is the major site for removing abnormal RBCs during blood circulation, and HX patients can experience splenomegaly. Indeed, both Piezo1cx/cx; vav1-cre and Piezo1cx/+; vav1-cre mice have significantly larger spleens compared to wild type mice ( Fig. 1F and Fig. S1C ). Therefore, our blood-specific Piezo1 GOF model recapitulates HX conditions and it provides a unique in vivo setting to study this inherited disease, as well as explore the connection between RBC dehydration and blood-borne parasitic diseases in vivo.
Next, we infected the knock-in mice with a rodent specific Plasmodium species, P. berghei ANKA, engineered to express GFP to enable fluorescence-based parasitemia analysis (14) . Intravenous injection of 1x10 5 parasite-infected RBCs caused wild type C57B/6 mice to die between day 6 and 8, consistent with previous literature (15) (Fig. 2A) . To evaluate the function of Piezo1 GOF in malarial infection, we generated constitutive knock-in Piezo1 GOF mice by crossing Piezo1cx/cx with cmv-cre, a cre driver expressed ubiquitously (16) . Remarkably, Piezo1 cx/cx; cmv-cre and Piezo1 cx/+; cmvcre mice (all on C57B/6 genetic background, described in Methods) survived as long as 24 and 19 days, respectively, suggesting that Piezo1 GOF confers protection against Plasmodium infection in vivo ( Fig. 2A) . Importantly, the blood cell-specific Piezo1 GOF mice, both Piezo1cx/cx; vav1-cre and Piezo1cx/+; vav1-cre, had post-infection survival rates indistinguishable from constitutive knock-in animals (for both heterozygotes and homozygotes), suggesting that Piezo1 GOF in hematopoietic lineages is sufficient to drive the protection ( Fig. 2A ).
Cerebral malaria is the most pernicious form of human severe malaria, causing more acute deaths than any other malarial symptoms including severe anemia (17) . To evaluate the occurrence of cerebral malaria in our model, Evans blue dye was injected into infected mice. This showed blue dye leakage into brain parenchyma on day 6 in all wild type mice (n=8) due to a disrupted blood-brain barrier (BBB) (Fig. 2B , wild type), indicating experimental cerebral malaria (ECM). Remarkably, the BBB of Piezo1cx/+; vav1-cre mice (n=7) remained intact even at the end of their life, suggesting that Piezo1 GOF expression completely protects animals from BBB breakdown, a key component of ECM (Fig. 2B) . Next, we analyzed the parasitemia post P. berghei infection in wild type and knock-in animals by measuring the percentage of RBCs that are GFP-positive by flow cytometry. During the first week of infection, knock-in animals (both constitutive and blood-specific) had significantly lower parasitemia compared to wild type, suggesting that expression of Piezo1 GOF allele in blood cells reduces Plasmodium development in vivo (Fig. 2C ). Parasitemia reached 6-12% in wild type animals at time of death (Fig. 2C ). Knock-in animals exhibited a slow increase in parasitemia, eventually leading to severe hyperparasitemia (up to 70% parasitemia), but did not develop signs for ECM (Fig.   2D ). Eventually, Piezo1 GOF mice succumbed to severe anemia instead of cerebral malaria, since the HGB level was significantly lower (2.85±2.5 g/dL, n=3) in Piezo1 cx/+; vav1-cre blood 18 days after infection compared to uninfected knock-in mice (14.02± 0.16 g/dL, n=5, p<0.002) (18) . The decrease in parasitemia observed in knock-in mice during the first week is readily explained by reduced infection rates due to dehydrated RBCs (see also below, Fig. 3 ). The lack of ECM that leads to hyperparasitemia is potentially due to altered immune responses to P. berghei infection in Piezo1 GOF mice. This may arise due to cell autonomous roles of Piezo1 GOF in white blood cells.
Alternatively, slower parasite replication may allow Piezo1 GOF mice to develop increased ability to mount a protective immune response. To test if this protection was an indirect effect secondary to initial low infection rates (Fig. 2C) , we infected wild type mice with reduced pathogen load (4x10 4 parasitized RBCs) and showed that reduced initial infection rate does not by itself give rise to the phenotype observed in knock-in mice (Fig. S2A) . Together, our data demonstrate that overactive
Piezo1 in blood cells considerably reduces Plasmodium growth and protects mice from cerebral malaria. We hypothesize that RBC dehydration (also associated with HX) is a leading cause of the reduced parasitemia observed in Piezo1 GOF animals. However, the mechanism involved in protection from severe malaria will have to await future investigations into a potential role of GOF Piezo1 allele in RBCs and/or in immune cells.
The genetic data above suggest that RBC dehydration plays an important role in reducing P. berghei infection during the first week in vivo. To explore whether acute RBC dehydration induced by Piezo1 activation is also protective in human RBCs against P. falciparum infections, we used Yoda1, the Piezo1-specific agonist (19) to treat human RBCs and then infected these cells with P. falciparum, in vitro. Culturing human RBCs with P. falciparum in the presence of Yoda1 dose-dependently reduced the parasitemia after 48h by up to 80% (Fig 3A) . A strong reduction was already observed when purified late stage parasites were incubated in the presence of Yoda1 and parasitemia was determined 18h later at the ring stage (Fig 3B) . Scanning electron microscopy showed that Yoda1 treated RBCs displayed a morphology resembling human echinocytes, with a typical dehydrated shape (Fig 3C) . To confirm that the effect of Yoda1 is through activation of RBC Piezo1 and not through direct action on the parasite (even though Plasmodium species do not have Piezo orthologues), human RBCs were first pre-incubated with Yoda1 for 10 min, extensively washed and then mixed with purified late stage parasites that were close to egress. Again, next day ring stage parasitemia was strongly reduced with respect to controls, revealing that the reduction in parasitemia is due to an overactive Piezo1 channel and not to Yoda1 activity on the parasite (Fig 3D) . It also indicated that the short Yoda1 pre-treatment had a protective effect for a prolonged period of time.
Taken together, these observations confirm that the results we observed in mice are also relevant to human RBCs (10) .
These findings raise a conundrum: If HX is protective against malaria infection and cerebral malaria, why is then HX not described at all in people of African descent, where malaria is highly prevalent?
Given the mild phenotype of HX patients (often asymptomatic) (13) (Fig 4A-B) . A1988V mutation only exists in African population with 0.8% allelic frequency (inset in Fig.   4A ). Surprisingly, we found that E756del has an allelic frequency of 18% in African population (inset in Fig 4B) , such that approximately one third of the African populations carry at least one copy of the E756del mutation (Fig 4E) . To confirm if these mutations are indeed GOF mutations, we recorded mechanically activated currents and found that both A1988V and E756del mutations were activated normally by mechanical force but had significantly longer inactivation times (τ) compared to wild type, similar to R2456H, a GOF allele with the longest inactivation time among all HX mutations (6) (Fig   4C-D) . Therefore, Piezo1 GOF mutations, similar to those causing HX in Caucasian families (6) , exist in African population. We used population genetics to determine if A1988V and E756del display signatures of being under positive selection in African populations. While the mutation A1988V was only detected in African populations, its frequency remains low (0.8%, inset Fig. 4A ) and is unlikely to be strongly selected (Table 2S) Table 2S and Fig 3S) . These findings are consistent with positive selection for E756del in African populations, however, do not provide conclusive evidence (22) .
Because of its high frequency (in contrast to the A1988V), we were able to acquire blood samples from healthy volunteer African American donors to test whether E756del causes HX-like RBC dehydration, and importantly, whether it confers resistance to P. falciparum infections of RBCs. We obtained 25 whole blood samples and used white blood cells to sequence the exon containing E756del. Nine of the donors were tested heterozygote for E756del. Scanning electron microscopy images showed the presence of RBCs with echinocyte and stomatocyte morphologies in all three carriers we examined ( Figure 5A ). Remarkably, we found that RBCs from all 9 donors were dehydrated ( Fig. 5B-C) , also similar to RBCs from known xerocytosis patients. This suggests that RBC dehydration (due to expression of Piezo1 GOF allele) is unexpectedly common in African populations. Next, we infected both non-carrier and E756del carrier RBCs with P. falciparum in vitro (genotypes blinded from experimenters) (23) . Our data showed that parasitemia was significantly lower for E756del heterozygous carriers relative to non-carriers at both 48hr and 96hr post infection (Fig. 5D ). In addition, we used a more quantitative method based on SYBR green labeling of parasite DNA to measure the parasitemia. Our results show that parasitemia (normalized to the non-carrier control) for carriers' blood was significantly lower than controls at 48hr, 96hr and 144hr post infection ( Fig. 5E ), consistent with Giemsa staining data. Together, our data demonstrate that E756del is a common Piezo1 GOF mutation in African populations and that it confers resistance to RBC infection by P. falciparum at least in vitro.
Here, we generated a mouse xerocytosis model and demonstrate that overactive mechanically activated Piezo1 channel in blood cells strongly protects animals from Plasmodium infection by significantly reducing RBC infection and preventing cerebral malaria. Strikingly, we identified a Piezo1 GOF mutation prevalent in populations of African descent that causes dehydrated RBCs, similar to HX patients. This is surprising, as HX is thought to be a very rare disorder that mainly afflicts Caucasians (6, 7, 8) . The donors that carry this allele are apparently asymptomatic as they were registered as healthy blood donors. However, we do not have any health records associated with these individuals, and full clinical evaluation of individuals carrying this allele will be of high interest.
Remarkably, the mutation considerably reduces P. falciparum infection rates. We conclude that HXlike condition is much more common than previously anticipated and might confer protection against P. falciparum. Despite the experimental evidence above, E756del was not detected as a strong candidate by recent genome-wide association studies (GWAS) that aimed to identify genetic loci for severe malaria resistance (24) . This is potentially due to GWAS limitations and the complexity of this particular genetic locus. GWAS samples have high levels of genetic diversity and are underrepresented in reference panels of genetic variation (25) . Also, E756del is in a region with multiple short tandem repeats so that imputation of this mutation into current GWAS datasets is not straightforward. In the future, analysis of epidemiological data will reveal whether this Piezo1 variant is indeed associated with protection against severe malaria (25) . In addition, clinical characterization of individuals with the E756del allele will shed further light on the range of phenotypes that are associated with Piezo1 GOF expression, including anemia, splenomegaly, as well as various aspects of cardiovascular function (26, 27, 28) . Supplemental Table 2 . Piezo1 missense and in-frame indel mutations enriched in African population.
Mouse lines

All animal procedures were approved by the Institutional Animal Care and Use Committees of The Scripps Research Institute (TSRI).
Piezo1cx/cx; vav1-cre, Piezo1cx/+; vav1-cre, Piezo1cx/cx; cmv-cre, Piezo1cx/+; cmv-cre mice were generated by breeding Piezo1 cx/cx with vav1-cre (12) (The Jackson Laboratory, stock# 018968) and cmv-cre(16) (The Jackson Laboratory stock# 006054), respectively. Piezo1 GOF mice were generated and maintained on C57BL/6 background. Both vav1-cre and cmv-cre mice were backcrossed at least 10 generations to C57BL/6. 
P. berghei infections and parasitemia measurement by flow cytometry
Blood-brain barrier assay
When P. berghei infected displayed either experimental cerebral malaria (including ataxia, convulsion, paralysis and/or coma) or severe anemia (immobility and pale blood color), 2% Evans Blue (SigmaAldrich, dissolved in sterile saline) was intravenously injected into P. berghei infected at 5ml/kg body weight. After 45-60 min, euthanized mice were transcardially perfused with Phosphate Buffer Solution and 4% paraformaldehyde before brains were dissected.
Scanning Electron Microscope
Samples of mouse blood were added to ice cold buffered saline (10mM NaCl, 155mM KCl, 10mM glucose and 1 mM magnesium chloride) before being fixed in 2.5% glutaraldehyde in 0. 
Osmotic fragility test
Blood was diluted at 1:8 into isotonic saline (0.9% NaCl) containing 2 mM HEPES, pH 7.4. 10 µl of the diluted blood was pipetted into each well (in a row) on a 96-well round-bottom plate. Separate rows were used for separate samples. 225 µl tonicity solutions made from saline solutions at concentration of 0, 20, 25, 30, 35, 40, 45, 50, 55, 60, 80, and 100%. The plate was incubated for 5min at room temperature followed by 5 min centrifuge at 1000xg. 150 µl supernatant was transferred to 96-well flat bottom plate for absorbance reading at 540nm using Cytation3 (BioTek, Winooski, VT).
The data was analyzed using 4-parameter sigmoidal nonlinear regression.
Piezo1 GOF mice generation
The targeting strategy was based on the NCBI transcript NM_001037298. for the rapidly-adapting currents, accordingly to previous reports (6) and using the fast time constant giving a value of inactivation time (τ) per responsive cell used for analysis. Channel kinetic properties between WT and mutant Piezo1 were compared using Student's t-test.
Cell culture and transient transfection
Piezo1 KO HEK cells (11) were grown in Dulbecco's modified Eagle's medium containing 4.5 mg/ml glucose, 10% fetal bovine serum, 1× antibiotics/antimycotics. Cells were plated in 6-well plates and transfected using lipofectamines 2000 (Invitrogen by ThermoFisher Scientific, Carlsbad, CA), according to the manufacturer's instruction. Human or mouse Piezo1 mutations fused to IREStdTomato was transfected at 1.4µg per well (6-well plate) for Fluorescent imaging plate reader (see below). To measure calcium signals, ultrasensitive sensor GCaMP6 (29) were transfected at 0.6µg per well (6-well plate). Cells were incubated for 2 days before electrophysiology experiments.
Fluorescent imaging plate reader (384-well format)
After transfection, the cells were dissociated from 6-well plates and re-seeded into 384-well plate, at 12,000 cells per well. The plate was incubated for 2 days then washed with assay buffer (1× HBSS, 10 mM HEPES, pH7.4) using a ELx405 CW plate washer (BioTek, Winooski, VT). Fluorescence was monitored on a fluorescent imaging plate reader (FLIPR) Tetra. A 10-mM stock solution of Yoda1 in dimethyl sulfoxide (DMSO) was used resulting in a maximum of 1% DMSO in the assay. 10 µM Yoda1 was used in initial screens for searching gain-of-function mutations (compared to wild type).
Positive hits were then validated by using a series of Yoda1 concentrations. Concentration-response curves were fitted using a sigmoidal dose-response at variable slope (GraphPad Prism, La Jolla, CA).
Real time quantitative PCR.
Total RNA was isolated from mouse whole blood by Quick-RNA Whole Blood (Zymo Research, Irvine, CA). 500 ng total RNA was used to generate 1st strand cDNA using the Quantitect reverse transcription kit (Qiagen). Real time PCR assays were set up using GoTaq qPCR Master Mix 
Population genetic analysis
We obtained minor allele and genotype frequencies from the Exome Aggregation Consortium (ExAC) (19) and the 1000 Genomes Project (21) . 2504 genomes were analyzed, 661 from African and 1843 from non-African ancestries. Wright's fixation index (F ST ), a measure of population differentiation, was calculated as follows:
where is the mean allele frequency and ! ! is the allele frequency variance between the populations. The 1000 Genomes browser (http://phase3browser.1000genomes.org) was used to determine that no alleles were in linkage disequilibrium with E756del (estimated r 2 values were <0.05). Hardy-Weinberg equilibrium was estimated using the classical binomial expansion to determine the expected genotype frequencies and x 2 tests. use. Cultures were monitored every one to two days via Giemsa-stained thin smears.
Parasitemia Determination
Asynchronous P. falciparum parasites (Dd2 strain) were cultured in standard conditions (as described above), then synchronized twice via sorbitol (31) and grown to 7% parasitemia at the late trophozoite/schizont stage. Patient blood was obtained from TSRI Normal blood donor service, washed and centrifuged three times (at 800 x g for 5 min at 4 0 C) with RPMI only and once with complete media (as above) (32), with any visible buffy coat being removed after each spin. All blood samples were given a numerical designation and allele status was not determined until after all data collection was completed.
Parasite growth was determined in two independent ways: absolute parasitemia determination via thin-blood smear after Giemsa staining, and inferred parasite growth via the SYBR Green I-based fluorescence assay (33) . For the absolute parasitemia determination by thin blood smear, parasites were established, starting from the 7% parasitemia cultures above and diluted using the corresponding patient RBCs, in a 10 mL culture at 5% hematocrit and 0.5% parasitemia (the same as for the Giemsa absolute parasitemia determination assay). Cultures were then grown for 4 days and parasitemia measurements were taken every 2 days. For the SYBR green I inferred parasitemia determination assay, when parasite burden is estimated based upon DNA content, parasites were cultured in 100 µL volumes in 96-well plates at 5% hematocrit and 0.5% parasitemia with at least 5 replicates per time point. Parasites were plated on three 96-well black plates with clear bottoms (Fisher Scientific). (One surrogate plate was used for measurement every two days, with DNA content determined by SYBR Green I incorporation of lysed parasites). Relative parasitemia was determined by fluorescence measurement, background was determined using uninfected RBCs and subtracted, then relative parasite burden was determined via normalization against a known O+ WT blood sample. In both cases all measurements were taken for all samples, genotypes were then assigned to numbered patient samples, wild type vs heterozygote samples were averaged at each time point, and average parasitemia values were compared. 
